Lacosamide Arrow (Lacosamide)

Lacosamide enhances the slow inactivation of voltage‑gated sodium channels in neuronal membranes, stabilizing hyper‑excitable neurons and diminishing the rapid firing that underlies seizure activity. This mechanism differs from classic sodium‑channel blockers that affect fast inactivation.

The specific dose of Lacosamide Arrow is determined by the prescribing clinician based on the patient’s age, renal function, concomitant medications, and therapeutic response. Dosing is individualized and should follow the prescriber’s instructions and local labeling.

Safety of lacosamide during pregnancy or lactation has not been fully established. Prescribers should weigh potential benefits against possible risks, and women who are pregnant, planning pregnancy, or breastfeeding should discuss treatment options with their healthcare provider.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Compared with older sodium‑channel blockers such as carbamazepine, lacosamide selectively enhances slow inactivation, which may result in a different side‑effect profile and lower risk of drug‑induced hyponatremia. It is often used when patients need additional seizure control beyond first‑line agents.

Lacosamide Arrow should be stored at ambient temperature, below 25 °C, in the original packaging to protect it from moisture and light. Keep the product out of reach of children and do not use if the packaging is damaged.

The medication is taken orally, usually as a tablet, and may be swallowed whole with water. It can be taken with or without food, but patients should follow the prescriber’s guidance on timing relative to other medicines to ensure consistent absorption.

Although uncommon, serious adverse reactions can include suicidal thoughts, severe skin reactions such as Stevens‑Johnson syndrome, cardiac arrhythmias, and hypersensitivity reactions. Patients should seek immediate medical attention if they experience mood changes, rash, chest pain, or signs of an allergic response.

Lacosamide Arrow is contraindicated in individuals with known hypersensitivity to lacosamide or any of its excipients. Caution is advised for patients with significant cardiac conduction disorders, severe renal impairment, or those taking interacting medications that could markedly alter lacosamide levels.